Ocean Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.03	0.03	0.06
Cash & Cash Equivalents	1.03	0.03	0.06
Cash Growth	788.79%	-43.33%	-
Other Current Assets	0	1.81	0.02
Total Current Assets	1.03	1.84	0.08
Total Assets	1.03	1.84	0.08
Accounts Payable	16.05	11.44	6.56
Current Debt	12.05	0.78	0
Other Current Liabilities	2.75	0.45	0.18
Total Current Liabilities	30.85	12.66	6.74
Other Long-Term Liabilities	45.4	0	0
Total Long-Term Liabilities	45.4	0	0
Total Liabilities	76.26	12.66	6.74
Total Debt	12.05	0.78	0
Debt Growth	1427.38%	-	-
Retained Earnings	-179.2	-81.59	-64.23
Shareholders' Equity	-75.22	-10.82	-6.66
Net Cash / Debt	-11.02	-0.74	0.06
Net Cash Per Share	-0.41	-0.04	0.00
Working Capital	-29.82	-10.82	-6.66
Book Value Per Share	-2.83	-0.62	-0.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).